B. Braun is notifying customers who purchased certain Aesculap knee systems to temporarily cease implanting them while the company addresses a “possible malfunction.” In a Nov. 16 letter sent to customers worldwide, the company said a “locally accumulated number of aseptic loosenings have been reported to us in connection with the univation X system. ln […]
Aesculap recently launched its M.blue hydrocephalus valve. The valve is adjustable gravitational valve that features an integrated fixed pressure differential valve during the most active time of the day, according to the company. The fixed pressure differential valve addresses posture changes. “We are very pleased to be able to continue to provide healthcare teams with […]
Surgical instrument maker Dextera Surgical and B. Braun subsidiary Aesculap said yesterday that they closed the $17.3 million deal to buy Dextera out of Chapter 11 bankruptcy. Redwood City, Calif.- based Dextera, formerly known as Cardica, agreed to the buyout in December 2017. The consummation Feb. 20 saw Dextera receive $13.6 million; another $2 million went into two-year escrow, $900,000 went to repay […]
New studies for umbilical cord allografts and tumor targeting were published this week while another company received European CE Marking. Here are some medtech stories we missed this week but thought were still worth mentioning. 1. AMNIOX touts new umbilical cord study AMNIOX Medical announced that it has published the results of 3 studies that demonstrate […]
B. Braun Medical subsidiary Aesculap said today that it won FDA approval for its ActivL artificial disc indicated for the treatment of 1-level lumbar degenerative disc disease. The ActivL is designed as an alternative to spinal fusion surgery, the Center Valley, Pa.-based company said, and is the 1st lumbar disc with a mobile ultra high molecular […]
The Limerick, Pa.-based medical device company said its "preliminary financial goals" for 2013 are for sales growth of 11%-13% and adjusted EPS of $4.70-$4.90.
The new slate of directors for Olympus Corp. (TYO:7733) is already drawing fire from foreign investors in the endoscopy giant, after its entire board resigned en masse over a $1.7 billion accounting scandal that’s slashed its valuation by about 50% since October.
Group purchasing organization Premier said it signed a raft of supply deals for a variety of medical device products.
The Charlotte-based GPO said it signed deals for endomechanical, trocar, suture and topical skin adhesives with 16 companies.
Veteran surgical devices maker and B. Braun Medical Inc. subsidiary Aesculap Inc. snapped up Aragon Surgical Inc. and its radiofrequency electrosurgical instruments for tissue fusion and cutting.
Aragon’s Caiman instruments are the only radiofrequency devices on the market with an articulating end to allow surgeons more maneuverability with tissue fusion and cutting during surgery.
Aesculap, Inc. Acquires Aragon Surgical, Inc.
Misonix Inc. (NSDQ:MSON) spiked a U.S. distribution deal with Aesculap Inc. for its SonaStar surgical aspiration system, saying it will sell the device direct through its own sales operation.
The new arrangement becomes effective Oct. 18.
Misonix said it will use its 75-person sales force to market the device, which is used to remove hard and soft tumors during neurological and general surgeries.